(Q51191944)

1 April 2018

title

Contemporary surgical management of HIV-associated facial lipoatrophy. (English)

1 reference

1 April 2018

author name string

Funk E

series ordinal

1

1 reference

1 April 2018

Bressler FJ

series ordinal

2

1 reference

1 April 2018

Brissett AE

series ordinal

3

1 reference

1 April 2018

publication date

1 June 2006

1 reference

1 April 2018

Otolaryngology—Head and Neck Surgery

published in

1 reference

1 April 2018

volume

134

1 reference

1 April 2018

issue

6

1 reference

1 April 2018

page(s)

1015-1022

1 reference

1 April 2018

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

Facial atrophy in HIV-related fat redistribution syndrome: anatomic evaluation and surgical reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

The use of custom-designed midfacial and submalar implants in the treatment of facial wasting syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

Incidence of lipoatrophy and lipohypertrophy in the women's interagency HIV study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

Use of recombinant human growth hormone in HIV-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

Treatment of facial fat atrophy related to treatment with protease inhibitors by autologous fat injection in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

Correction of facial lipoatrophy in HIV-infected patients on highly active antiretroviral therapy by injection of autologous fatty tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

Soft tissue augmentation using sculptra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.OTOHNS.2006.01.005

10.1016/J.OTOHNS.2006.01.005

21 January 2018

Identifiers

DOI

1 reference

1 April 2018

release_mobvlywopzhm7j7k7d34eaagzm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mobvlywopzhm7j7k7d34eaagzm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16730549

1 reference

1 April 2018